Merrimack Pharmaceuticals Inc (MACK) Stock
MACK is no longer traded. Merrimack Pharmaceuticals was delisted from the Nasdaq in May 2024.
Prices on this page are historical; the last trade was May 15, 2024 at $15.13.
Merrimack Pharmaceuticals stock price history
MACK final trading statistics
- Final close
- $15.13
- Final trading day
- May 15, 2024
- Market cap at delisting
- $223.75M
- Shares outstanding
- 14.79M
- Final 52-week range
- $11.53 – $15.89
- Avg. volume (final 3 mo.)
- 173,387
- All-time high (split-adj.)
- $52.93 · Apr 2015
- All-time low (split-adj.)
- $1.63 · Mar 2020
- Return since IPO
- -35.3%
- Beta
- 1.42
- Book value / share
- $15.25
- Price / book
- 0.99
Merrimack Pharmaceuticals annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2023 | $0.00 | -$1.2M | -$0.08 |
| FY2022 | -$445.0K | -$1.5M | -$0.78 |
| FY2021 | $0.00 | -$2.5M | -$2.68 |
| FY2020 | $0.00 | -$3.0M | -$1.40 |
| FY2019 | $0.00 | -$21.3M | -$2.79 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Merrimack Pharmaceuticals Inc
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company in the United States. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
Merrimack Pharmaceuticals stock FAQ
What happened to Merrimack Pharmaceuticals stock?
Merrimack Pharmaceuticals stock was delisted from the Nasdaq. Its final close was $15.13 on May 15, 2024.
Is MACK stock still trading?
No. MACK was delisted from the Nasdaq in May 2024 and no longer trades on a U.S. exchange.
What was the last price of MACK stock?
MACK closed at $15.13 on its final trading day, May 15, 2024, for a market value of about $223.75M.
What were Merrimack Pharmaceuticals's revenue and earnings in its last full fiscal year?
Merrimack Pharmaceuticals reported revenue of $0.00 and net income of -$1.2M in fiscal 2023, its last full year as a public company.
When did Merrimack Pharmaceuticals go public?
Merrimack Pharmaceuticals Inc stock began trading on March 29, 2012.